Effect of liraglutide on epicardial adipose tissue thickness with echocardiography in patients with obese type 2 diabetes mellitus
ConclusionsLiraglutide is beneficial to the decrease of EAT. EAT thickness can be measured with echocardiography to evaluate the effect of liraglutide in obese T2DM patients.
Source: International Journal of Diabetes in Developing Countries - Category: Endocrinology Source Type: research
More News: Diabetes | Diabetes Mellitus | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Insulin | Obesity | Study | Victoza